SCHEMBL9419616

SCHEMBL9419616

OCCN1CCN(CCCCN2c3ccccc3Oc3ccccc32)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 5/20 0.62
ADRA2A P08913 4/20 0.62
DRD2 P14416 4/20 0.62
ADRA2B P18089 4/20 0.62
ADRA2C P18825 4/20 0.62
SLC6A2 P23975 4/20 0.62
HTR2A P28223 4/20 0.62
SLC6A4 P31645 4/20 0.62
ADRA1A P35348 4/20 0.62
HRH1 P35367 4/20 0.62
DRD3 P35462 4/20 0.62
SLC6A3 Q01959 4/20 0.62
KCNH2 Q12809 4/20 0.62
DRD1 P21728 3/20 0.62
SIGMAR1 Q99720 3/20 0.62
CHRM2 P08172 2/20 0.62
CHRM1 P11229 2/20 0.62
OPRM1 P35372 2/20 0.62
HRH3 Q9Y5N1 2/20 0.62
CACNA1B Q00975 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13305239 0.86 KDM1A (0.60) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL7468275 0.85 DRD2 (0.63) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL8251326 0.85 DRD2 (0.53) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL9419635 0.84 CACNA1B (0.50) SIGMAR1CACNA1BKDM1ACACNA1H
SCHEMBL13305145 0.83 KDM1A (0.64) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL13305140 0.83 KDM1A (0.67) HTR1ADRD2SIGMAR1CACNA1BHTR6
SCHEMBL6102599 0.83 CACNA1B (0.51) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL13305143 0.82 KDM1A (0.65) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL13305256 0.82 KDM1A (0.61) HTR1AADRA2ADRD2ADRA2BADRA2C
SCHEMBL30216960 0.82 SIGMAR1 (0.46) HTR1AADRA2ADRD2ADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371081-A Useful in potentiating the cytotoxic effect of chemotherapeutic agents ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 1994-12-06 US claimed
WO-1993003729-A1 N-SUBSTITUTED PHENOXAZINES FOR TREATING MULTIDRUG RESISTANT CANCER CELLS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 WO claimed
US-5371081-A Useful in potentiating the cytotoxic effect of chemotherapeutic agents ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 1994-12-06 US disclosed
WO-1993003729-A1 N-SUBSTITUTED PHENOXAZINES FOR TREATING MULTIDRUG RESISTANT CANCER CELLS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1993-03-04 WO disclosed